Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with ... Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.65 | -11.221449851 | 50.35 | 50.35 | 38.5 | 6089 | 39.83141872 | CS |
| 4 | -5.3 | -10.6 | 50 | 50.82 | 38.5 | 3046 | 40.67272134 | CS |
| 12 | 0.76 | 1.72963131543 | 43.94 | 55.36 | 38.5 | 2347 | 44.00799346 | CS |
| 26 | -33.3 | -42.6923076923 | 78 | 78.73 | 35.931 | 3280 | 49.05681781 | CS |
| 52 | -24.927 | -35.8007669439 | 69.627 | 83.12 | 35.931 | 1881 | 51.76252784 | CS |
| 156 | 4.7 | 11.75 | 40 | 141.742 | 33.42 | 1639 | 82.20744352 | CS |
| 260 | 13 | 41.0094637224 | 31.7 | 141.742 | 11.14 | 1485 | 78.39868272 | CS |
Trading2retire
10年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。